Log In
Print this Print this

Ventana PD-L1 (SP142) Assay

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionIn vitro diagnostic uses immunohistochemistry (IHC) technology to visually enhance and score PD-L1 protein on tumor-infiltrating immune cells
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose PD-L1 expression status in patients with metastatic urothelial cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today